Press

PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb

PathAI Receives Both FDA 510(k) Clearance and CE Mark for AISight^TM Dx Platform

PathAI Research Shows Power of Artificial Intelligence to Predict Biomarkers from H&E Images

PathAI Appoints Brandon Eldredge as Chief Financial Officer

PathAI Appoints Elizabeth Storti as Chief People Officer

PathAI To Present Three Abstracts at International Liver Congress 2022